Early and out-of-hospital use of COVID-19 convalescent plasma: An international assessment of utilization and feasibility.

Arwa Z Al-RiyamiLise EstcourtNaomi Rahimi-Levene Evan M Bloch Ruchika GoelPierre TiberghienJean-Baptiste ThibertMie Topholm BruunDana V Devine Richard R Gammon Silvano WendelMichel Toungouz NevessignskyRada M Grubovic Rastvorceva Adaeze OrehIñigo RomonKarin van den BergJunichi KitazawaGopal Kumar Patidar Cynthia So-OsmanErica M Woodnull null

Published in: Vox sanguinis (2022)

Early administration of CCP remains a potential option in COVID-19 management in countries with existing OOH/HT programmes. Legislation and regulatory bodies should consider OOH/HT practice for transfusion in future pandemics.

Keyphrases

coronavirus disease
sars cov
healthcare
primary care
cardiac surgery
transcription factor
respiratory syndrome coronavirus
current status
risk assessment
adverse drug